vancomycin has been researched along with Insulin Sensitivity in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, K; Clish, CB; Fujisaka, S; Herzog, C; Kahn, CR; Pacheco, JA; Soto, M | 1 |
| Chaix, A; Chang, MW; Knight, R; Marotz, CA; Panda, S; Saghatelian, A; Xu, ZZ; Zarrinpar, A | 1 |
| Blaak, EE; Goossens, GH; Hermes, GDA; Reijnders, D; Smidt, H; Zoetendal, EG | 1 |
| Ackermans, MT; Blaak, EE; Dallinga-Thie, GM; de Vos, WM; Fuentes, S; Groen, AK; Hoekstra, JB; Holleman, F; Holst, JJ; Jonker, L; Kema, IP; Knaapen, M; Knop, FK; Kootte, RS; Nieuwdorp, M; Out, C; Reijnders, D; Reuling, I; Romijn, JA; Serlie, MJ; Soeters, MR; Stroes, ES; van der Ley, C; van Nood, E; Vrieze, A; Zoetendal, EG | 1 |
| Hwang, I; Ka, S; Kim, JB; Kim, YN; Kim, YR; Lee, HY; Park, YJ; Seok, YJ; Seong, JK | 1 |
2 trial(s) available for vancomycin and Insulin Sensitivity
| Article | Year |
|---|---|
Short-Term Microbiota Manipulation and Forearm Substrate Metabolism in Obese Men: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Double-Blind Method; Fasting; Fatty Acids, Nonesterified; Forearm; Gastrointestinal Microbiome; Glucose Intolerance; Humans; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Obesity; Placebos; Postprandial Period; Vancomycin | 2018 |
Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
Topics: Administration, Oral; Adult; Aged; Animals; Anti-Bacterial Agents; Bile Acids and Salts; Feces; Glucose; Humans; Insulin Resistance; Intestines; Male; Metabolic Syndrome; Mice; Microbiota; Middle Aged; Obesity; Single-Blind Method; Vancomycin | 2014 |
3 other study(ies) available for vancomycin and Insulin Sensitivity
| Article | Year |
|---|---|
Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism.
Topics: Animals; Anti-Bacterial Agents; Anxiety; Brain; Diet, High-Fat; Gastrointestinal Microbiome; Inflammation; Insulin; Insulin Resistance; Male; Metronidazole; Mice; Mice, Inbred C57BL; Microbiota; Obesity; RNA, Ribosomal, 16S; Vancomycin | 2018 |
Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Bile Acids and Salts; Blood Glucose; Body Composition; Body Weight; Cecum; Colon; Fatty Acids, Volatile; Gastrointestinal Microbiome; Gene Expression Regulation; Glucose; Homeostasis; Insulin; Insulin Resistance; Male; Metronidazole; Mice; Mice, Inbred C57BL; Neomycin; Obesity; RNA, Ribosomal, 16S; Vancomycin | 2018 |
Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Bacteroidetes; Blood Glucose; Blotting, Western; Cell Line, Tumor; Diet, High-Fat; Gastrointestinal Tract; Glucagon-Like Peptide 1; Gram-Positive Bacteria; Humans; Insulin; Insulin Resistance; Metabolomics; Mice, Inbred C57BL; Microbiota; Obesity; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin | 2015 |